Cover Image

Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients

Muhammad Nasir Kalam,1 Muhammad Fawad Rasool,2 Faleh Alqahtani,3 Imran Imran,4 Asim Ur Rehman,1 Naveed Ahmed1 1Department of Pharmacy, Quaid-i-Azam University, Islamabad, 45320, Pakistan; 2Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, 60800, Pakistan; 3...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kalam MN (Author), Rasool MF (Author), Alqahtani F (Author), Imran I (Author), Rehman AU (Author), Ahmed N (Author)
Format:	Book
Published:	Dove Medical Press, 2021-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Physiologically Based Pharmacokinetic Model to Predict Systemic Ondansetron Concentration in Liver Cirrhosis Patients
by: Faleh Alqahtani, et al.
Published: (2023)

Development and Evaluation of Physiologically Based Pharmacokinetic Drug-Disease Models for Predicting Rifampicin Exposure in Tuberculosis and Cirrhosis Populations
by: Muhammad F. Rasool, et al.
Published: (2019)

A Comprehensive Physiologically Based Pharmacokinetic Model for Predicting Vildagliptin Pharmacokinetics: Insights into Dosing in Renal Impairment
by: Mahnoor Pasha, et al.
Published: (2024)

A Physiologically Based Pharmacokinetic Model for Predicting Diazepam Pharmacokinetics after Intravenous, Oral, Intranasal, and Rectal Applications
by: Sundus Khalid, et al.
Published: (2021)

A physiologically based pharmacokinetic model of cefepime to predict its pharmacokinetics in healthy, pediatric and disease populations
by: Muhammad Talha Zahid, et al.
Published: (2023)

Physiologically-based pharmacokinetic modeling for single and multiple dosing regimens of ceftriaxone in healthy and chronic kidney disease populations: a tool for model-informed precision dosing
by: Fawaz Alasmari, et al.
Published: (2023)

A Comprehensive Physiologically Based Pharmacokinetic Model of Nadolol in Adults with Renal Disease and Pediatrics with Supraventricular Tachycardia
by: Samia Kalsoom, et al.
Published: (2024)

Simultaneously Predicting the Pharmacokinetics of CES1-Metabolized Drugs and Their Metabolites Using Physiologically Based Pharmacokinetic Model in Cirrhosis Subjects
by: Xin Luo, et al.
Published: (2024)

Development and Evaluation of a Physiologically Based Pharmacokinetic Model of Labetalol in Healthy and Diseased Populations
by: Hafsa Hafsa, et al.
Published: (2022)

Propranolol can correct prolonged QT intervals in patients with cirrhosis
by: Huanqin Han, et al.
Published: (2024)

Physiologically Based Pharmacokinetic Modeling in Pregnant Women Suggests Minor Decrease in Maternal Exposure to Olanzapine
by: Liang Zheng, et al.
Published: (2022)

Prediction of lisinopril pediatric dose from the reference adult dose by employing a physiologically based pharmacokinetic model
by: Memoona Rashid, et al.
Published: (2020)

The Effect of Liver and Kidney Disease on the Pharmacokinetics of Clozapine and Sildenafil: A Physiologically Based Pharmacokinetic Modeling
by: Ghoneim AM, et al.
Published: (2020)

A physiologically‐based pharmacokinetic modeling approach for dosing amiodarone in children on ECMO
by: Venkata K. Yellepeddi, et al.
Published: (2024)

Use of physiologically‐based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity
by: Jacqueline G. Gerhart, et al.
Published: (2022)

Physiologically based pharmacokinetic modeling of tadalafil to inform pediatric dose selection in children with pulmonary arterial hypertension
by: Jessica Rehmel, et al.
Published: (2022)

Prediction of pediatric dose of tirzepatide from the reference adult dose using physiologically based pharmacokinetic modelling
by: Ruifang Guan, et al.
Published: (2023)

Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Predicting Haloperidol Exposure in Healthy and Disease Populations
by: Mohammed S. Alasmari, et al.
Published: (2022)

Physiologically-based pharmacokinetic modelling and dosing evaluation of gentamicin in neonates using PhysPK
by: Hinojal Zazo, et al.
Published: (2022)

Physiologically based pharmacokinetic modeling of daptomycin dose optimization in pediatric patients with renal impairment
by: Lingling Ye, et al.
Published: (2022)

Animal model investigation suggests betamethasone alters the pharmacokinetics of amikacin
by: Seth Kwabena Amponsah, et al.
Published: (2018)

Predicting the correct dose in children: Role of computational Pediatric Physiological‐based pharmacokinetics modeling tools
by: Xu Zhou, et al.
Published: (2023)

Physiologically based pharmacokinetic modeling for dose optimization of quinine-phenobarbital coadministration in patients with cerebral malaria
by: Teerachat Sae‐heng, et al.
Published: (2022)

Liver Cirrhosis Update and Current Challenges
Published: (2017)

Liver Cirrhosis Debates and Current Challenges
Published: (2019)

Pharmacokinetic Parameters and Over-Responsiveness of Iranian Population to Propranolol
by: Ebrahim Salehifar, et al.
Published: (2017)

Informing Pharmacokinetic Models With Physiological Data: Oral Population Modeling of L-Serine in Humans
by: J. R. Bosley, et al.
Published: (2021)

MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer
by: Elisa Callegari, et al.
Published: (2019)

Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model
by: Cheng Cui, et al.
Published: (2020)

Development of a physiologically based pharmacokinetic model of fostemsavir and its pivotal application to support dosing in pregnancy
by: Farzaneh Salem, et al.
Published: (2024)

Application of Physiologically‐Based and Population Pharmacokinetic Modeling for Dose Finding and Confirmation During the Pediatric Development of Moxifloxacin
by: Stefan Willmann, et al.
Published: (2019)

VALUE OF AMINOTRANSFERASES IN LIVER CIRRHOSIS
by: Miroslava Mihaylova, et al.
Published: (2024)

Macrophage cytotherapy on liver cirrhosis
by: Dabing Ping, et al.
Published: (2023)

Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins
by: Luna Prieto Garcia, et al.
Published: (2024)

Model-Informed Precision Dosing of Isoniazid: Parametric Population Pharmacokinetics Model Repository
by: Ju G, et al.
Published: (2024)

Unravelling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling
by: Xiaoxia eYang, et al.
Published: (2015)

Pharmacokinetic Characterization of Supinoxin and Its Physiologically Based Pharmacokinetic Modeling in Rats
by: Yoo-Kyung Song, et al.
Published: (2021)

Development of a pediatric physiologically-based pharmacokinetic model to support recommended dosing of atezolizumab in children with solid tumors
by: Weize Huang, et al.
Published: (2022)

Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic Modelling
by: Tom G. Jacobs, et al.
Published: (2023)

Development and evaluation of patient information leaflet for liver cirrhosis patients
by: Siddheesh Rajpurohit, et al.
Published: (2023)